Health & Medicine
-

Study Shows an HIV Medication Slows Malignant Colorectal Cancer
New clinical research demonstrates that lamivudine, a reverse transcriptase inhibitor often used in HIV treatment, prevented disease progression in 25% of patients with metastatic colorectal cancer who were on their fourth line of treatment
Latest Research Articles
-

Human Fatalities Linked to Animal Tranquilizer in Ontario
-

Study Shows that Thinking About Pain Makes it More Painful
-

Drinking Water and Staying Well Hydrated May Lower the Risk of Heart Failure
-

Drug-Resistant, Pathogenic Yeasts Can Thrive on the Surface of Apples, Other Fruits
-

New Research Says Some Types of Asthma could Protect Us Against Severe COVID-19
-

Two or Three Avocadoes per Week Can Reduce the Risk of Cardiovascular Diseases
-

Tokyo Celebrates ‘Hanami’ Cherry Blossoms Viewing After 2 Years of Cancellations
-

Reducing the Consumption of Ultra-Processed Food Could Help Improve the Environment
-

Recent Study Indicates Tiny Molecule Medications Can Target RNA, Opening New Avenues for Illness Therapy
-

New Study Shows Treatment for Severe Alopecia with an Arthritis Drug
-

Deadly Fungus That Pierces Ants’ Gut Cells are Wiping Out Invasive Ant Colonies in the U.S.
Belly Fat: New Study Reveals Sleep Deprivation Causes Abdominal Obesity






